BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1703903)

  • 41. Low leukocyte contamination without filtration by preparation of platelet concentrates in cylindrical bags with the buffy-coat method.
    Kostelijk EH; Loos JA; Veldman HA; de Korte D
    Vox Sang; 2000; 79(2):87-93. PubMed ID: 11054046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system.
    Larsson S; Sandgren P; Sjödin A; Vesterinen M; Gulliksson H
    Transfusion; 2005 May; 45(5):743-51. PubMed ID: 15847664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
    Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
    Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of plateletpheresis systems].
    Kretschmer V
    Beitr Infusionsther; 1991; 28():162-76. PubMed ID: 1725615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].
    Budde U
    Beitr Infusionther Klin Ernahr; 1986; 15():75-81. PubMed ID: 3092802
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of the DiaMed Impact R to test platelet function in stored platelet concentrates.
    Morrison A; Hornsey VS; Prowse CV; Macgregor IR
    Vox Sang; 2007 Aug; 93(2):166-72. PubMed ID: 17683361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative evaluation of 3 leukocyte filters for thrombocyte concentrates].
    Reiser M; Kádár JG; Borberg H
    Beitr Infusionsther; 1991; 28():216-9. PubMed ID: 1725623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plateletapheresis with the new cell separator AS-104.
    Kretschmer V; Middelbeck T; Gerlach A; Göddecke W; Söhngen D; Prinz H; Pflüger HH
    Beitr Infusionsther; 1990; 26():117-22. PubMed ID: 1703808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Initial results with the new cell separator AS 104].
    Kretschmer V; See A; Söhngen D; Bachem M; Kadar JG; Borberg H; Pelzer H; Zöfel P
    Beitr Infusionsther; 1988; 21():113-7. PubMed ID: 2462955
    [No Abstract]   [Full Text] [Related]  

  • 54. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Leukocyte content of erythrocyte concentrates without buffy coat].
    Mädler J
    Z Gesamte Inn Med; 1986 Jul; 41(13):372-4. PubMed ID: 3765735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
    Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
    Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy of 2 different leukocyte filters for erythrocyte concentrates].
    Barth A; Passerini M; Oppliger R; Spycher M; Nydegger U
    Schweiz Med Wochenschr; 1993 Jun; 123(22):1160-4. PubMed ID: 8322051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Filtration of buffy coat-free erythrocyte suspensions in additive solution].
    Dietrich K; Dietrich G; Kretschmer V; Eckle R; Heins M
    Beitr Infusionsther; 1992; 30():162-5. PubMed ID: 1284696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Filtration of buffy coat free red cell concentrates in additive solution.
    Dietrich G; Dietrich K; Kretschmer V; Eckle R
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):151-6. PubMed ID: 1498559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation of small volume, leuko and erythrocyte very poor platelet concentrates.
    Valbonesi M; Angelini G; Malfanti L; Lercari G; Fella M; Calderisi S; Anselmo A; Balistreri M
    Int J Artif Organs; 1986 May; 9(3):189-92. PubMed ID: 3733246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.